Chapter 5. Novel Antipsychotics
- 1 January 1993
- book chapter
- Published by Elsevier
- Vol. 28, 39-47
- https://doi.org/10.1016/s0065-7743(08)60875-1
Abstract
No abstract availableThis publication has 78 references indexed in Scilit:
- Endocrine and receptor pharmacology of serotonergic anxiolytics, antipsychotics and antidepressantsLife Sciences, 1992
- Synthesis of carbon‐14 and tritium labelled analogs of the noval antischizophrenic agent clozapineJournal of Labelled Compounds and Radiopharmaceuticals, 1992
- The cloned dopamine D2 receptor reveals different densities for dopamine receptor antagonist ligands. Implications for human brain positron emission tomographyEuropean Journal of Pharmacology: Molecular Pharmacology, 1992
- (Aminoalkoxy)chromones. Selective .sigma. receptor ligandsJournal of Medicinal Chemistry, 1992
- New classes of selective D-1 dopamine receptor antagonist provide further evidence for two directions of D-1:D-2 interactionNeurochemistry International, 1992
- The GI T-lymphocyte theory of schizophrenia: Some new observationsMedical Hypotheses, 1992
- Metabolism of Clozapine† by NeutrophilsDrug Safety, 1992
- Possible Role of Free Radical Formation in Drug-Induced AgranulocytosisDrug Safety, 1992
- On the Possible Mechanisms and Predictability of Clozapine†-Induced AgranulocytosisDrug Safety, 1992
- Mechanisms of Clozapine†-Induced AgranulocytosisDrug Safety, 1992